NO953072D0 - Anvendelse av inhibitorer av ornitinaminotransferase for fremstilling av et medikament for behandling av Alzheimers sykdom - Google Patents

Anvendelse av inhibitorer av ornitinaminotransferase for fremstilling av et medikament for behandling av Alzheimers sykdom

Info

Publication number
NO953072D0
NO953072D0 NO953072A NO953072A NO953072D0 NO 953072 D0 NO953072 D0 NO 953072D0 NO 953072 A NO953072 A NO 953072A NO 953072 A NO953072 A NO 953072A NO 953072 D0 NO953072 D0 NO 953072D0
Authority
NO
Norway
Prior art keywords
alzheimer
medicament
inhibitors
disease
manufacture
Prior art date
Application number
NO953072A
Other languages
English (en)
Other versions
NO953072L (no
Inventor
Nikolaus Seiler
Jean-Bernard Ducep
Karin Camille Jund
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO953072L publication Critical patent/NO953072L/no
Publication of NO953072D0 publication Critical patent/NO953072D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO953072A 1993-02-05 1995-08-04 Anvendelse av inhibitorer av ornitinaminotransferase for fremstilling av et medikament for behandling av Alzheimers sykdom NO953072D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93400303A EP0609630A1 (en) 1993-02-05 1993-02-05 Use of inhibitors of ornithine aminotransferase for the manufacture of a medicament for the treatment of Alzheimer's disease
PCT/US1993/011283 WO1994017795A1 (en) 1993-02-05 1993-11-19 Use of inhibitors of ornithine aminotransferase for the manufacture of a medicament for the treatment of alzheimer's disease

Publications (2)

Publication Number Publication Date
NO953072L NO953072L (no) 1995-08-04
NO953072D0 true NO953072D0 (no) 1995-08-04

Family

ID=8214677

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953072A NO953072D0 (no) 1993-02-05 1995-08-04 Anvendelse av inhibitorer av ornitinaminotransferase for fremstilling av et medikament for behandling av Alzheimers sykdom

Country Status (14)

Country Link
US (1) US5637768A (no)
EP (2) EP0609630A1 (no)
JP (1) JPH08506577A (no)
AU (1) AU682330B2 (no)
CA (1) CA2152796A1 (no)
FI (1) FI953725A0 (no)
HU (1) HUT73173A (no)
IL (1) IL107737A (no)
MX (1) MX9400911A (no)
NO (1) NO953072D0 (no)
NZ (2) NZ258461A (no)
TW (1) TW383337B (no)
WO (1) WO1994017795A1 (no)
ZA (1) ZA938836B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003043616A2 (en) * 2001-11-16 2003-05-30 Als Therapy Development Foundation, Inc. Treatment of neurodegenerative disorders through the modulation of the polyamine pathway
US7030126B2 (en) * 2001-11-16 2006-04-18 Als Therapy Development Foundation, Inc. Use of polyamine analogs for amyotrophic lateral sclerosis
CN111362828A (zh) * 2020-03-30 2020-07-03 山西医科大学 一种18f标记的氟丙酰化鸟氨酸及其制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE77367T1 (de) * 1988-02-05 1992-07-15 Merrell Dow Pharma 5-substituierte ornithin-derivate.

Also Published As

Publication number Publication date
IL107737A (en) 1998-12-27
NO953072L (no) 1995-08-04
ZA938836B (en) 1994-08-02
EP0682515A1 (en) 1995-11-22
AU682330B2 (en) 1997-10-02
WO1994017795A1 (en) 1994-08-18
FI953725A (fi) 1995-08-04
IL107737A0 (en) 1994-02-27
HU9502320D0 (en) 1996-05-28
NZ280983A (en) 1997-07-27
US5637768A (en) 1997-06-10
TW383337B (en) 2000-03-01
NZ258461A (en) 1997-03-24
FI953725A0 (fi) 1995-08-04
AU5614394A (en) 1994-08-29
EP0609630A1 (en) 1994-08-10
CA2152796A1 (en) 1994-08-18
JPH08506577A (ja) 1996-07-16
MX9400911A (es) 1994-08-31
HUT73173A (en) 1996-06-28

Similar Documents

Publication Publication Date Title
NO981911D0 (no) Anvendelse av rhodaninderivater for fremstilling av et medikament for behandling av Alzheimer's sykdom
NO962568D0 (no) Anvendelse av PLA2 inhibitorer som behandling for Alzheimers sykdom
IT9022471A0 (it) Procedimento e apparecchiatura per l'abbinamento univoco di farmaci corrispondenti a una terapia pescritta a un determinato paziente
NO944928D0 (no) Fremgangsmåter for inhibering av Alzheimers sykdom
NO306235B1 (no) Anvendelse av et legemiddel for behandling av artritt
NO20026199L (no) Forbindelser for behandling av Alzheimers sykdom
NO20022531D0 (no) Vaksine for forebyggelse og behandling av Alzheimer og amyloidrelaterte sykdommer
NO306850B1 (no) Anvendelse av 5-halo-2-pyrimidinon-deoksyribose eller 5-halo-2-pyrimidinon for fremstilling av et medikament for behandling av leversykdom
HK1005425A1 (en) Use of 2-(3,4-dimethoxycinnamoyl)-aminobenzoic acid for the manufacture of a medicament for the treatment of restenosis
NO20001869L (no) FremgangsmÕte for behandling av Alzheimers sykdom
NO962752D0 (no) Anvendelse av 2,3-diaryl-1-benzopyranderivater ved fremstilling av et medikament for behandling og forebyggelse av benvevstap og osteoporose
NO20000771D0 (no) Anvendelse av fankinon for behandling av Alzheimers sykdom
IL117695A0 (en) Pharmaceutical agents for the treatment of alzheimer's disease
NO953072D0 (no) Anvendelse av inhibitorer av ornitinaminotransferase for fremstilling av et medikament for behandling av Alzheimers sykdom
FR2710539B1 (fr) Ensemble d'aiguille chirurgicale.
DK0642338T3 (da) Anvendelse af (E)-2-(p-fluorphenethyl)-3-fluorallylamin i behandlingen af Alzheimers sygdom
DK0703781T3 (da) Anvendelse af Efaroxan og derivater deraf til fremstilling af et lægemiddel til behandling af Parkinsons sygdom
NO307126B1 (no) Anvendelse av biologisk aktive ureidoderivater for fremstilling av et medikament for bruk i behandlingen av lentivirusindusert sykdom
NO961180D0 (no) Transdermal anordning inneholdende (E)-2-(p-fluorfenetyl)-3-fluorallylamin for behandling av Alzheimers sykdom
FI933872A0 (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,3,4-bensotriazepin-5(4h)-on-derivat
DE69404370T2 (de) Gelatinase A zur Behandlung von der Alzheimerschen Krankheit
DK8893D0 (da) Medicament for treatment or prevention of disease
PT731710E (pt) Composicoes contendo timosine alpha 1 destinadas ao tratamento de pacientes sofrendo duma doenca de figado descompensado
FI951041A (fi) (S)-(-)-alfa-etyyli-2-okso-1-pyrrolidiiniasetamidin käyttö valmistettaessa farmaseuttinen valmiste ahdistuksen hoitoon
SI0664121T1 (en) Use of raloxifene and its analogs for the manufacture of a medicament for the treatment of atherosclerose and ischaemic heart disease

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application